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Abstract: Lassa virus (LASV) is the causative agent of Lassa hemorrhagic fever, a lethal disease
endemic to Western Africa. LASV entry is mediated by the viral envelope glycoprotein (GP), a class I
membrane fusogen and the sole viral surface antigen. Previous studies have identified components
of the LASV entry pathway, including several cellular receptors and the requirement of endosomal
acidification for infection. Here, we first demonstrate that incubation at a physiological temperature
and pH consistent with the late endosome is sufficient to render pseudovirions, bearing LASV GP,
non-infectious. Antibody binding indicates that this loss of infectivity is due to a conformational
change in GP. Finally, we developed a single-particle fluorescence assay to directly visualize individual
pseudovirions undergoing LASV GP-mediated lipid mixing with a supported planar bilayer. We report
that exposure to endosomal pH at a physiologic temperature is sufficient to trigger GP-mediated lipid
mixing. Furthermore, while a cellular receptor is not necessary to trigger lipid mixing, the presence
of lysosomal-associated membrane protein 1 (LAMP1) increases the kinetics of lipid mixing at an
endosomal pH. Furthermore, we find that LAMP1 permits robust lipid mixing under less acidic
conditions than in its absence. These findings clarify our understanding of LASV GP-mediated fusion
and the role of LAMP1 binding.
Keywords: Lassa virus; virus entry; membrane fusion; single-particle fusion
1. Introduction
Lassa virus (LASV) is an arenavirus endemic to Western Africa. An outbreak of Lassa fever in
Nigeria led to 4841 suspected cases and 197 confirmed deaths in the first twenty-one weeks of 2020 [1].
The sequelae of Lassa fever include sensorineural deafness in 25% of survivors and a greater than 80%
chance of maternal and/or fetal death in pregnant patients in their third trimester [2,3]. Due to the
deadly nature of Lassa hemorrhagic fever, LASV is classified as a Category A priority pathogen by the
United States Centers for Disease Control and Prevention.
The LASV envelope glycoprotein (GP) coordinates the fusion of the viral envelope with the
endosomal membrane of the target cell [4]. GP is synthesized as a precursor glycoprotein complex that
is subsequently processed by cellular proteases into subunits GP1 and GP2, as well as a long and stable
signal peptide (SSP) [5,6]. During viral entry, GP1 is responsible for binding at least two identified
cellular receptors, α-dystroglycan (αDG) and lysosomal-associated membrane protein 1 (LAMP1) [7,8].
Studies to date suggest a model in which GP1 first binds α-DG on the cell surface, which causes the
cell to internalize the virus into an endosome via macropinocytosis [9]. The acidification of the late
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endosome causes GP to undergo an affinity switch from αDG to LAMP1 [10]. Implicated in this affinity
switch are histidines H92, H93, and H230, which are located adjacent to the GP1 receptor-binding site
and undergo conformational changes in response to protonation [11,12]. A crystallographic structure
of GP at a neutral pH and cryo-electron tomography structures determined under acidic conditions
have shown that acidic pH is sufficient to initiate conformational changes in GP1 [13,14].
The prevailing model of class I fusion holds that GP2 sits in a kinetically trapped, metastable
pre-fusion conformation. The transition to the post-fusion conformation is facilitated by a trigger, which
lowers the activation energy for exothermic collapse [15]. During fusion triggering, the GP2 subunit
undergoes putative conformational rearrangements that involve the adoption of a transient extended
intermediate in which the fusion loop is inserted into the target membrane [16]. The subsequent
refolding of GP2 brings the target and viral membranes into close approximation, inducing fusion.
Like other class I viral fusogens, the formation of the six-helix bundle is thought to drive membrane
fusion [17–19].
Previous studies in LASV and lymphocytic choriomeningitis virus (LCMV) have highlighted the
importance of acidic pH in arenavirus entry [14,20–26], with some cell–cell fusion studies suggesting
that a pH as low as 3.5 may be required for LASV GP-mediated fusion to occur [27,28]. Of particular
note, exposure to a pH consistent with the late endosome at a physiological temperature was shown to
trigger the fusion of LCMV [29]. Here, we show that exposure to low pH is sufficient at a physiological
temperature to trigger conformational changes in LASV GP related to membrane fusion. Furthermore,
we show directly by a single-particle fusion assay that exposure to pH 5.0 is sufficient to trigger LASV
GP-mediated lipid mixing in the absence of receptor binding. Finally, we demonstrate conclusively
that LAMP1 binding is dispensable for LASV GP-mediated lipid mixing. However, its presence in
the target membrane increases the kinetics of lipid mixing, facilitating robust lipid mixing at a less
acidic pH.
2. Materials and Methods
2.1. Cell Culture
HEK293T cells were cultured in DMEM (Thermo Fisher, Waltham, MA, USA) supplemented
with 10% cosmic calf serum (GE Healthcare, Chicago, IL, USA), l-glutamine (Thermo Fisher),
and penicillin–streptomycin (Thermo Fisher) at 37 ◦C and 5% CO2 and were used to generate
pseudovirions as described below. Vero cells were cultured in DMEM supplemented with 10%
fetal bovine serum (FBS; Gemini Bio), l-glutamine, and penicillin–streptomycin at 37 ◦C and 5%
CO2 and were used for infectivity assays with pseudovirions bearing GP and HA. DF1 chicken
fibroblast cells were cultured in RPMI (Thermo Fisher) supplemented with 10% FBS, l-glutamine,
and penicillin–streptomycin at 37 ◦C and 5% CO2, and were used for infectivity assays with
pseudovirions bearing ALV env, as mammalian cells are neither susceptible nor permissive to
infection by ALV subtype A.
2.2. Plasmid DNA
The pcDNA3 plasmid encoding LASV GP from the Josiah strain was provided by Dr. Melinda
Brindley at the University of Georgia [11]. The pVRC8400 plasmid encoding IAV HA (A/Vietnam/2004)
was provided by Dr. Peter Kwong at the Vaccine Research Center. HA0 was formed by site-directed
mutagenesis as previously described [30]. ALV subtype A Env was provided by Dr. John Coffin at
Tufts University. The soluble LAMP1 expression construct was provided by Dr. Juha Huiskonen at the
University of Oxford [14].
2.3. Pseudotype Production
HEK293T cells were transfected with 10 µg of plasmid containing the glycoprotein of interest in a
10 cm dish at 80% confluency. PEI MAX was used for transfection at a mass ratio of 4:1 PEI to plasmid
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DNA. Cells were infected with VSV∆G-GFP-VSVG (Kerafast) 24 h post transfection at an MOI of 3 [31].
Supernatant was collected 24 h post infection and ultra-centrifugated over a 10% sucrose cushion at
160,000× g for 90 min. Supernatant was aspirated and pellets were resuspended in phosphate-buffered
saline (PBS). The pseudovirus was aliquoted and frozen at −80 ◦C until use. Bald particles were
generated following an identical protocol, with the exception of the omission of a glycoprotein.
2.4. Virus Infectivity Assays
Infections were performed in Vero cells for studies with LASV GP and IAV HA, and in DF-1 cells
for ALV Env. 10 µL of concentrated pseudovirus were diluted in 0.1 M phosphate buffer (for pH 7.0
and 6.0) or 0.1 M acetate buffer (for pH 5.5 through 4.0) in temperature-controlled conditions. Virions
were then brought back to neutral pH in 5× volume of 0.1 M phosphate buffer at pH 7.0 while still at
their experimental temperatures, and then immediately serially diluted in room temperature DMEM
for infection.
Target cells were infected with the pre-incubated virus and were incubated for one hour at 37 ◦C
with rocking every 15 min. Fresh DMEM was then added to the cells. At 5 h post infection, cells were
collected by trypsinization and assayed for GFP expression using flow cytometry on a FACSCALIBUR.
Statistical significance was calculated using a two-way ANOVA with an alpha of 0.05.
2.5. LASV GP Antibody Capture ELISA
Purified VSV pseudotypes were treated with either a phosphate buffer at pH 6.0 or 7.0, or acetate
buffer at pH 5.5 or 5.0 at 37 ◦C or on ice for 30 min. The virions were then brought back to a neutral pH,
as described above, at their respective temperatures and bound to an ELISA plate. The plate was then
blocked with a 3% BSA solution for 1 h and washed with PBS three times. The immobilized virions
were then probed with non-neutralizing (26.5E, 24.6C) or neutralizing antibodies (12.1F, 37.2D, 37.7H)
for 1 h, washed three times with PBS, and probed with an HRP-conjugated rabbit anti-human IgG1
antibody (Abcam, Cambridge, UK) [32]. The plate was developed with SureBlue™ TMB 1-Component
Microwell Peroxidase Substrate (SeraCare, Milford, MA, USA) for twenty minutes and read in a
Synergy H1 Biotek plate reader.
2.6. LAMP1 Purification
HEK293F cells were transfected with plasmid encoding the full lumenal domain of LAMP1 with a
6×His tag and grown for 6 days. PEI MAX was used as the transfection reagent as indicated above.
Supernatant was collected and circulated over Ni-NTA agarose beads (Thermo Fisher, Waltham, MA,
USA) overnight at 4 ◦C. The beads were then washed with PBS with 50 mM imidazole. LAMP1 was
eluted from the beads with PBS with 250 mM imidazole. The protein was then dialyzed into PBS and
stored at −80 ◦C in frozen aliquots.
2.7. Liposome Formation
Liposomes were formed as described in Floyd et al. [33].
Briefly, 1-oleoyl-2-palmitoyl-sn-glycero-3-phosphocholine (POPC) (Avanti Polar Lipids, Alabaster, AL, USA),
1,2,dioleoyl-sn-glycero-3-phosphocholine (DOPC) (Avanti Polar Lipids, Alabaster, AL, USA), cholesterol,
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(carboxyfluorescein) (FLPE) (Avanti Polar Lipids,
Alabaster, AL, USA), and either 1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic
acid)succinyl] (Ni-NTA DOGS) (Avanti Polar Lipids, Alabaster, AL, USA) or bovine ganglioside GD1a
(Millipore Sigma, Burlington, MA, USA) were mixed at a molar ratio of 4:4:2:0.2:0.1. Chloroform was
evaporated under nitrogen gas, and lipids were resuspended in PBS to a working concentration of
10 mg/mL. The lipid mixture underwent seven freeze/thaw cycles in liquid nitrogen followed by extrusion
through a 200 nm pore size polycarbonate membrane filter (Whatman, Maidstone, UK) 21 times.
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2.8. Labeling Virions
Virions were labeled by incubating with 2 mM DiD (Thermo Fisher, Waltham, MA, USA) for two
hours at room temperature. Unbound DiD was removed by passage over a Zeba desalting column
(Thermo Fisher, Waltham, MA, USA) equilibrated in PBS. Labeled virus was used immediately in
single-particle lipid mixing assays.
2.9. Single-Virion Lipid Mixing Assay
The single-virion lipid mixing assay was adapted from that described by Floyd et al. [33].
Pre-drilled quartz slides and glass coverslips were immersed in distilled water and sonicated for
20 min. They were then moved to 1 M KOH and the sonication was repeated. The slides were rinsed
with distilled water, before being sonicated in acetone, and rinsed again. The coverslips and slides
were then allowed to dry overnight. The dry slides were then cleaned in an plasma cleaner (Harrick
Plasma, Ithaca, NY, USA) for 2 min. Flow cells were then constructed with the slides and coverslips.
Each flow cell was rinsed with PBS, and then 100 µL of liposomes were injected into the flow cell
by a syringe pump at 80 µL/min. The liposomes were allowed to incubate for twenty minutes at
room temperature before the channel was again rinsed with 300 µL of PBS. Labeled virions were then
pumped into the channel at 40 µL/min and allowed to incubate for 20 min to allow virions to bind
to the membrane. The channel was then rinsed with PBS again to remove unbound virus. The slide
was then placed on the stage of a prism-based TIRF microscope. Pre-warmed buffer was pumped into
the flow cell while acquiring movies at 100 ms exposures (10 Hz) for a minimum of 3 min, or until no
more dequenching events could be seen. The analysis of the dequenching events was performed in
Matlab (MathWorks, Waltham, MA, USA). The interval between 50% loss of CF fluorescence resulting
from acidification and DiD dequenching was extracted for each event and compiled into histograms.
The histograms displayed a rise and fall in the frequency of lipid mixing events. This indicates that
multiple rate-limiting steps are necessary before the arrival of lipid mixing; a single rate-limiting
step would have given rise to an exponentially distributed histogram of the frequency of events.
We therefore considered the kinetic scheme
A→ I1 → I2 → · · · → IN → B
where A represents the pre-fusion state, B represents the state after lipid mixing, and I1, I2, . . . IN are the
N rate-limiting intermediate states. The probability density function for this scheme, which describes





where k is the rate constant and N is the number of rate-determining steps. The histograms of the time
intervals were fit to the gamma distribution using a least squares algorithm in Matlab. The mean time
to dequenching was then determined by calculating 〈t〉 = N/k.
3. Results
3.1. The pH Sensitivity of LASV GP
We first sought to determine the pH sensitivity of LASV GP with a viral inactivation assay, a
common strategy used to study the pH dependence of viral fusogen function [34]. We therefore
formed GFP-encoding vesicular stomatitis virus (VSV) pseudovirions bearing GP from the Josiah
strain of LASV. This pseudotyping strategy has previously been used for mutagenic studies of LASV
GP, as well as for LASV vaccine trials [11,35]. VSV-GP pseudovirions were first incubated at 21 ◦C
for five or thirty minutes in buffer at pH values ranging from 5.0 to 7.0. The virions were returned
to a neutral pH while maintaining the temperature before they were used to infect Vero cells. GFP
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expression was assayed using flow cytometry five hours post infection. Above pH 5.0, no loss of
infectivity was seen after five minutes of incubation at 21 ◦C (Figure 1A). Infectivity was reduced
by approximately 13% when the virions were incubated at pH 5.0 for five minutes. A similar loss
of infectivity was seen for pseudovirions carrying H5 hemagglutinin (HA) from influenza, which is
known to be triggered by acidic pH [34,36]. When the virions were incubated at 37 ◦C and pH 5.5 for
five minutes, infectivity was reduced to 45%. Infectivity was further reduced by 90% when incubated
at pH 5.0 (Figure 1A). When the incubation was extended for thirty minutes, infectivity was reduced
by 90% at pH 5.5 (Figure 1B). Again, similar losses of infectivity were seen for particles carrying
HA. In contrast, no loss of infectivity was seen for pseudovirions carrying the envelope glycoprotein
from avian leukosis virus (ALV Env) following incubation for five or thirty minutes at pH 5.0 at all
temperatures tested (Figure 1). Finally, consistent with the model in which GP is kinetically trapped
in the metastable pre-fusion conformation, no loss of infectivity was observed at any pH while on
ice (Figure 1). These data demonstrate that incubation at pH 5.0 to 5.5 leads to loss of infectivity of
GP-bearing pseudovirions at a physiologic temperature.
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Figure 1. Exposure to low pH at physiological temperature inactivates LASV GP. VSV∆G-GFP-GP
viral pseudotypes were treated with either phosphate buffer at pH 6.0 or 7.0, or acetate buffer at pH 5.5
or 5.0 at the indicated temperature for (A) 5 min or (B) 30 min. Virus was subsequently brought back to
neutral pH and used to infect Vero cells. Infectivity was determined by measuring GFP expression
using flow cytometry. Infectivity was normalized to the percent of GFP-positive cells at the 21 ◦C
pH 7.0 condition for each virus. Assays were performed in biological triplicate with new viral preps,
and each biological replicate was performed in technical triplicate. Data are presented as the mean of
three biological replicates and error bars represent the standard error of the mean. An asterisk indicates
a statistically significant difference as compared to the case of pH 7 (p < 0.05) calculated using a one-way
ANOVA. The lack of an asterisk indicates no statistically significant difference as compared to pH 7.
3.2. Acidic pH Triggers Loss f Recognition by Neutralizing Antibodies
To further test whether exposure to acidic pH at a physiological temperature triggers a
conformational change in LASV GP, we evaluated the recognition by neutralizing antibodies 12.1F,
37.2D, and 37.7H using an enzyme-linked immunosorbent assay (ELISA). These antibodies recognize
epitopes that bridge both GP1 and GP2, making them highly specific for the pre-fusion conformation
of GP [13,32]. Virions were incubated at pH values ranging from 5.0 to 7.0 on ice or at 37 ◦C for thirty
minutes. The pH was then neutralized while maintaining temperature, and virions were subsequently
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bound to an ELISA plate at room temperature. We then probed for the presence of the pre-fusion
conformation of GP with neutralizing antibodies 12.1F, 37.2D, and 37.7H. Irrespective of temperature,
exposure to pH 6 or 7 led to no loss of antibody binding (Figure 2). At pH 5.5, moderate loss of binding
by only 37.7H was seen after a 37 ◦C incubation, whereas full binding was maintained after incubation
on ice. Incubation at pH 5.0 at 37 ◦C abrogated binding by approximately 50% in the case of 12.1F,
by more than 60% in the case of 37.2D, and by 75% in the case of 37.7H, whereas no loss of binding
of any antibody was seen after incubation on ice. In contrast, no loss of binding after incubation at
either temperature across the range of pH values was seen for the non-neutralizing antibodies 26.5E
and 24.6C (Figure 2) [32]. Taken together, the infectivity and antibody binding data suggest that GP
undergoes a pH-induced transition out of the pre-fusion conformation, concurrent with a loss of
function. Here again, only when incubations were performed at a physiological temperature did the
putative transition occur at a pH consistent with the late endosome.
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Figure 2. The binding tralizing and no -neutralizing antibodies to LASV GP after exposure to
acidic pH at physiologi erature. VSV∆ -GFP-GP viral pseudotypes wer treated with either
phosphate buffer at pH 6.0 or 7.0, or acetat ff r t .5 or 5.0 at the indicated temperature for 30 min.
Virus was subsequently brought back to neutral p and assayed for binding by non-neutralizing
(26.5E, 24.6C) and neutralizing antibodies (12.1F, 37.2D, 37.7H) by ELISA [32]. Data are presented as
the mean of three biological replicates and error bars represent standard error of the mean. An asterisk
indicates a statistically significant difference as compared to the case of incubation at 0 ◦C and pH
7 (p < 0.05.) calculated using a one-way ANOVA. The lack of an asterisk indicates no statistically
significant difference.
3.3. Acidic pH Triggers Lipid Mixing Mediated by LASV GP
Our observations thus far support a hypothesis in which acidic pH is sufficient to promote
the transition of GP from the pre-fusion to the post-fusion conformation. We sought to test this
hypothesis by dir ctly visualizing the pH-induced triggering o GP-mediat membrane fusion.
To this d, we developed a single-partic e lipid mixing assay adapted from thos used in studies
of influenza [33,37,38], West Nile virus [39], feline coronavirus [40], and VSV [41]. We formed a
planar lipid bilayer supported within a quartz microfluidic cell. Contained within the bilayer was
lipid-soluble 6-carboxyfluorescein (CF), a pH-sensitive dye used as a fluorescent pH indicator. VSV-GP
pseudovirions were generated as described above, but with the additional inclusion of HA with a
mutated furin cleavage site (HA0). This HA0 mutant is incapable of mediating fusion but enabled the
attachment of the virions to the lipid bilayer by way of binding sialic acid, which was included in the
bilayer in the form of the GD1a ganglioside. This approach allowed us to consider the role of pH in
GP-mediated lipid mixing indepen ently from the engageme t f a rece t r in th target membrane.
The viral m brane was labeled with th lipophilic fluorophore DiD t a concentrati n sufficient to
partially quench fluorescence. Based on the previous applications of this approach, we anticipated
that the hemifusion of the viral membrane and the planar bilayer would allow the diffusion of the
DiD into the bilayer, which would give rise to a sharp increase in fluorescence as the DiD dequenches.
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The DiD fluorescence then decays as the dye continues to diffuse into the planar bilayer. We bound
VSV-HA0-GP virions to the supported lipid bilayer in the microfluidic channel at pH 7.0 and imaged
the surface using prism-based total internal reflection fluorescence (TIRF) microscopy (Figure 3A).
Puncta of DiD fluorescence indicated the presence of virions attached to the surface. Pre-warmed
buffers at various pH values were then introduced into the flow cell with a syringe pump with the
continuous monitoring of fluorescence.
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the number of rate-determining steps leading to lipid mixing, and the average time to lipid mixing 
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Figure 3. LASV P ediates lipid mixing between fluorescently labeled virions and a supported
lipid bilayer. (A) Carto n of pseudovirions formed with a SV core, inactive HA0, and LASV GP,
hemifusing to a planar lipid bilayer supp rt t icroscope slide within a microfluidic
chamber. Pseudovirions er fl to the bilayer and allowed to ttach at neutral pH b way
of i lic ci i teraction. DiD fluorescence dequenching arose due to single pseudovirions
hemifusing to the sup orted bilayer up t ction of acidic pH. CF was inclu ed in the
supported bilayer in to provide a fluor scence indicator of pH. Fluor scence was detected
using the evanesc nt fi ld generated from the sim ltaneous tot l internal reflection of 642-nm and
532-nm lasers on a custom-built prism-based TIRF microscope. Movies were recorded at a 100 ms
exposure time (10 Hz) for a minimum of 1400 frames. (B) Frames from a single DiD dequenching
event at pH 5 acquired at the indicated time points, where Time = 0 was defined as a 50% decrease
in CF fluorescence. (C) Representative fluorescence traces (CF, red; DiD, blue) are from a single
dequenching event. The drop in CF fluorescence arises from the acidification of the buffer in the
channel. The subsequent spike in DiD fluorescence arises from dequenching as DiD diffuses into the
planar bilayer. The interval (t) between the 50% decrease in CF fluorescence and DiD dequenching was
extracted for kinetic analysis.
The introduction of pH 4.0 buffer pre-warmed to 37 ◦C induced a precipitous loss of CF fluorescence,
indicating the successful delivery of low pH buffer to the flow cell. Following the acidification of the
chamber, the DiD puncta exhibited the characteristic sharp increase and trailing loss of fluorescence
indicative of successful lipid mixing (Figure 3B, Movie S1). The integration of the fluorescence
intensity of each punctum allowed for the generation of CF and DiD fluorescence traces (Figure 3C).
Pseudovirions that had been incubated at acidic pH at 37 ◦C prior to binding to the planar bilayer
displayed no evidence of lipid mixing upon the introduction of acidic buffer to the flow cell. Similarly,
virions lacking GP and possessing only HA0 bound the surface but also did not display any evidence
of lipid mixing, indicating that the observed lipid mixing was mediated by GP (Movie S2).
To determine the kinetics of lipid mixing, we extracted the time interval between the drop
in CF fluorescence and the dequenching of DiD fluorescence. These int rvals wer compiled into
histogra s and fit to a gamma distribution, which allowed the det rmin tion of the rate constant,
the number of rate-determining steps leading to lipid mix g, and the verag time to li id mixing
(Figure 4A, Section Materials and Methods) [33,37]. This fitting procedure indicated that at pH 4.0,
there existed approximately 4.2 ± 0.1 rate-determining steps leading to lipid mixing, with a rate
constant of 0.31 ± 0.01 s−1, which yielded an average time to lipid mixing of 13.5 ± 0.5 s. Increasing
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the pH to 4.5 and 5.0 slowed the rate constant to 0.25 ± 0.01 and 0.19 ± 0.02, respectively, which
led to corresponding increases in the time to lipid mixing (Figure 4B,C, Movies S3,S4). However,
across all pH values considered, the number of rate-determining steps between acidification and lipid
mixing was consistently approximately 4 (Figure 4B). No lipid mixing was seen above pH 5.0 on the
timescale of our movies. Below pH 4.0, lipid mixing occurred too rapidly to accurately evaluate in this
assay. In summary, the timing of lipid mixing occurred in a pH-dependent manner, with the kinetics
decreasing with increasing pH. The number of rate-determining steps was not sensitive to pH.
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the interval of time between the 50% decrease in CF fluorescence and DiD dequenching was compiled
into a histogram and fit to a gamma distribution by a least-squares algorithm. (A) The histogram for
each pH considered, in the absence or presence of LAMP1, is shown with the gamma distribution fit
overlaid in red. N indicates the number of individual lipid mixing events. (B) For each experiment,
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was determined through the gamma distribution fitting of each histogram in A. (C) The rate constants
(k) determined from the gamma distribution fitting of each histogram in A. (D) The mean time to
dequenching, defined as N/k for a gamma distribution. Error bars reflect the 95% confidence intervals
determined in the fitting. An asterisk indicates a statistically significant difference as compared to the
case of LAMP1 at pH 5 (p < 0.05.) calculated using a one-way ANOVA.
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3.4. LAMP1 Increases the Kinetics of Lipid Mixing
We next asked whether the attachment of the virion to the target membrane by way of GP–LAMP1
interactions would affect the kinetics of lipid mixing. To this end, the single-virion lipid mixing
experiment was repeated using VSV-GP pseudovirions lacking HA0, and with a soluble form of
LAMP1 immobilized on the planar bilayer by way of a polyhistidine (6× His) tag bound to a Ni-NTA
lipid. Virions were bound to the supported bilayer at pH 5.5. As in the absence of LAMP1, pH 5.5 was
not sufficiently acidic to trigger lipid mixing. However, rapid lipid mixing was observed at pH 5.0 in
the presence of LAMP1 (Movie S5). Kinetic analysis indicated a rate constant and average time to lipid
mixing consistent with that observed at pH 4.0 in the absence of LAMP1 (Figure 4). The number of
rate-determining steps (4.1 ± 0.1) remained similar to that seen in the absence of LAMP1 (Figure 4B).
Thus, the interaction of GP with LAMP1 increased the kinetics of lipid mixing to an extent equivalent
to reducing the pH by approximately one unit. Here again, pseudovirions that had been pre-incubated
at an acidic pH at 37 ◦C prior to binding to the planar bilayer in the presence of LAMP1 displayed no
sign of lipid mixing after the introduction of acidic buffer to the flow cell.
4. Discussion
Here, we demonstrate that acidic pH alone is sufficient to induce the conversion of LASV GP to a
conformation that is unable to support entry into cells and unable to bind neutralizing antibodies that
are specific to the pre-fusion conformation of GP. Importantly, only at a physiological temperature is
pH 5.0, which approximates the pH of the most acidic endosomes [42], sufficiently acidic to promote
this transition. No loss of infectivity or loss of antibody binding was seen when virions were incubated
at room temperature or on ice at pH 5.0. This temperature-dependent transition to an irreversible
conformation is consistent with a kinetically trapped pre-fusion conformation of GP. This implies
that a large activation energy limits spontaneous transition out of the pre-fusion conformation into
a conformation with much lower free energy. Elevated temperature increases the probability of
spontaneously crossing this high activation energy, while the protonation of key residues in GP by the
acidic environment likely reduces the activation energy. Thus, reduced temperatures, which lower
the probability of crossing the activation energy, require more acidic pH to trigger conformational
changes in GP [43]. This underscores the importance of maintaining a physiological temperature when
characterizing the activity of glycoproteins such as LASV GP.
By attaching virions to a target membrane by orthogonal means—through HA0-mediated binding to
sialic acid—we have further provided direct evidence that acidic pH is sufficient to trigger LASV
GP-mediated lipid mixing in the absence of interaction with either αDG or LAMP1. Thus, no
receptor-binding event is strictly necessary to trigger GP-mediated lipid mixing. These data provide
support for the previous observation that the disruption of the αDG binding site through mutagenesis
only minimally affects cell–cell fusion [11]. These data also support previous studies indicating that
LAMP1 is not necessary for GP-mediated cell–cell fusion [21], nor is it strictly required for entry into
cells [20].
Our kinetic analysis of single-virion lipid mixing events indicates that the time from pH drop to
lipid mixing decreases at more acidic pH. This provides direct evidence for the pH-induced reduction
in the activation energy that kinetically traps GP in the pre-fusion conformation. Interestingly,
although the rate of lipid mixing increased with decreasing pH, the number of rate-determining steps
remained approximately constant across the pH range tested. This indicates that the mechanism
of GP-mediated lipid mixing is consistent across a range of pH values. This may be an indirect
observation of intermediate conformations in GP, which may resemble those postulated for other
class I viral fusogens, such as influenza HA and Ebola GP [16,30,43,44]. A cryo-electron tomography
study of GP documented a pH-induced transition of GP to a conformation distinct from the pre- and
post-fusion conformations [14], which may reflect an intermediate conformation achieved during
fusion. Alternatively, the observation of multiple rate-determining steps leading to lipid mixing may
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be an indication that multiple GP trimers need to engage the target membrane in order to promote
lipid mixing.
Finally, we have directly shown that the attachment of virions to the target membrane by way of
binding LAMP1 increases the kinetics of lipid mixing. When LAMP1 is present, lipid mixing occurs
at pH 5.0 at a rate approximately equal to the rate observed in the absence of LAMP1 at pH 4.0.
Thus, while LAMP1 is not necessary for GP to promote lipid mixing, LAMP1 increases the pH at
which GP-mediated lipid mixing occurs, thus facilitating LASV entry under less harsh conditions,
as previously suggested [20]. This indicates that LAMP1 and acidic pH synergistically reduce the
activation energy that limits GP conformational changes that lead to fusion. This observation is
entirely consistent with previous studies demonstrating that LAMP1 increased the pH at which GP
could mediate cell–cell fusion [21], and that virions enter by way of less acidic endosomes in cells
expressing LAMP1 as compared to cells lacking LAMP1 [20]. Taken together, the present and previous
studies provide a consistent understanding for the roles that endosomal pH and LAMP1 play in LASV
entry. Future studies will be aimed at probing the mechanism by which acidic pH and LAMP1 enable
GP conformational changes. This will likely require a combination of structure determination and
biophysical interrogations equipped to visualize GP conformational changes that lead to fusion.
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/12/7/716/s1,
Movie S1. Representative movie of single-virion lipid mixing events that occurred upon exposure to pH 4. The left
channel is a visualization of CF fluorescence used to mark the drop in pH. The right channel is a visualization of
the DiD fluorescence, which was used to visualize lipid mixing. Movies were recorded at 100ms for a minimum of
1400 frames; Movie S2. Representative movie of the single-virion lipid mixing experiment with VSV pseudotypes
bearing only HA0. The movie is presented as for Movie S1; Movie S3. Representative movie of single-virion
lipid mixing events that occurred upon exposure to pH 4.5. The movie is presented as for Movie S1; Movie S4.
Representative movie of single-virion lipid mixing events that occurred upon exposure to pH 5. The movie is
presented as for Movie S1; Movie S5. Representative movie of single-virion lipid mixing events that occurred
upon exposure to pH 5 in the presence of LAMP1. The movie is presented as for Movie S1.
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